Intranasal ketorolac for pain launched in the US, by Daiichi Sankyo's Luitpold Pharma
18 May 2011
Nancy Faigen
Please Login to read the full article.
18 May 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Archimedes wins US approval of Lazanda as first fentanyl nasal spray
- Pacira to raise $63m more as Exparel reaches the market and seeks new indication
- US FDA panel: Let anti-NGF studies move forward, despite 'severe' joint risks
- Post $40 mn IPO, AcelRx gets $20M loan for non-invasive PhIII opioid drug/device combo
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
